12/22/2025
Our bariatric weight loss programs (gastric sleeve, gastric bypass and bariatric revision) remained strong in 2025, in spite of the prevalence of GLP-1 drugs. This The New York Times article may explain why: https://www.nytimes.com/2025/12/21/health/older-people-glp1-weight.html?unlocked_article_code=1.-U8.ZQoU.zR8quZZ2lEXr&smid=em-share with Dr. Seun Sowemimo
CentraState Medical Center Atlantic Health
In some studies, half of patients stopped taking GLP-1s within a year despite the benefits, citing the expense and side effects.